Chlamydia Infection Diagnostics And Therapeutics Market By Product Type (Diagnostics, Therapeutics), By End User (Diagnostics, Therapeutics), By Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecasts (2017–2022)

Chlamydia Infection Diagnostics And Therapeutics Market By Product Type (Diagnostics, Therapeutics), By End User (Diagnostics, Therapeutics), By Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecasts (2017–2022)

ID: 5132 | Pages: 175 | December 2017 | Region: Global


The Global Chlamydia Infection Diagnostics and Therapeutics market size was around USD 2 billion in 2017. It is expected to grow at a CAGR of 6% to reach USD 2.68 billion by 2022.Chlamydia is a sexually transmitted disease. The symptoms do not occur early on. It is usually prevalent in areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade.

Increasing number of cases of these diseases better and complete reporting in emerging economies, augmenting screening coverage, improved funding for better R&D in this area, growing awareness regarding STDs in the developing countries along with the increased healthcare expenditures are the factors driving the growth of this market. Also accessibility to and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Furthermore, improved insurance coverage in the emerging economies augurs well for this market.However, the stigma associated with sexually transmitted diseases is the primary restraint of market growth.

Chlamydia Infection Diagnostics and Therapeutics Market is broadly segmented by product type and end user into diagnostics and therapeutics segments. Classification in diagnostics by product type entails Nucleic Acid Amplification Tests (NAATs), Direct Fluorescent Tests, and PCR. NAAT accounted for the largest market share in 2016 and is predicted to grow robustly in the forecast period. It is closely tailed by DFT in terms of CAGR. This is because NAATs are more sensitive and diagnose better. Classification in diagnostics by end user entails Hospitals, Specialty Clinics, and Diagnostic Centres. Classification in therapeutics by product type entails Macrolides, Quinolones, Sulphonamides, Tetracycline, and Aminopenicillins. Macrolides is expected to undergo high growth in the forecast period. It also captures the largest market share and is expected to stay at the top in the forecast period. Classification in therapeutics by end user entails Hospital Pharmacies, Drugstores, Retail Pharmacies, and Online Pharmacies.

Classification by geography entails North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America is the largest regional market while Asia Pacific is expected to be the fastest growing market worldwide.

Key players in the market include Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product Type                            

                              5.1.1 Introduction           

                              5.1.2 Diagnostics             

                                             5.1.2.1 Nucleic Acid Amplification Tests (NAATs)

                                             5.1.2.2 Direct Fluorescent Tests

                                             5.1.2.3 PCR

                              5.1.3 Therapeutics          

                                             5.1.3.1 Macrolides

                                             5.1.3.2 Quinolones

                                             5.1.3.3 Sulfonamides

                                             5.1.3.4 Tetracycline

                                             5.1.3.5 Aminopenicillins

                              5.1.4 Y-o-Y Growth Analysis, By Product Type     

                              5.1.5 Market Attractiveness Analysis, By Product Type    

                              5.1.6 Market Share Analysis, By Product Type     

               5.2 End User                     

                              5.2.1 Introduction           

                              5.2.2 Diagnostics             

                                             5.2.2.1 Hospitals

                                             5.2.2.2 Specialty Clinics

                                             5.2.2.3 Diagnostic Centers

                              5.2.3 Therapeutics          

                                             5.2.3.1 Hospital Pharmacies

                                             5.2.3.2 Drugstores

                                             5.2.3.3 Retail Pharmacies

                                             5.2.3.4 Online Pharmacies

                              5.2.4 Y-o-Y Growth Analysis, By End User             

                              5.2.5 Market Attractiveness Analysis, By End User            

                              5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product Type

                                             6.1.3.3 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product Type

                                             6.1.4.3 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product Type

                                             6.1.5.3 By End User

               6.2 North America                         

                              6.1.1 Introduction           

                              6.1.2 United States         

                              6.1.3 Canada     

               6.3 Europe                        

                              6.2.1 Introduction           

                              6.2.2 U.K            

                              6.2.3 Spain         

                              6.2.4 Germany  

                              6.2.5 Italy           

                              6.2.6 France      

               6.4 Asia-Pacific                

                              6.3.1 Introduction           

                              6.3.2 China        

                              6.3.3 India         

                              6.3.4 Japan        

                              6.3.5 Australia   

                              6.3.6 South Korea           

               6.5 Latin America                           

                              6.4.1 Introduction           

                              6.4.2 Brazil         

                              6.4.3 Argentina 

                              6.4.4 Mexico     

                              6.4.5 Rest of Latin America          

               6.6 Middle East & Africa              

                              6.5.1 Introduction           

                              6.5.2 Middle-East           

                              6.5.3 Africa        

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Bio Rad laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Novartis AG               

               8.3 F Hoffmann-La Roche                           

               8.4 Abbott Laboratories               

               8.5 Danaher                      

               8.6 bioMerieux                

               8.7 DiaSorin SpA                             

               8.8 Siemens AG               

               8.9 Thermo Fisher Scientific                       

               8.10 Becton Dickinson and Company                     

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Chlamydia Infection Diagnostics and Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  2. Global Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  3. Global Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  4. Global Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  5. Global Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  6. Global Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  7. Global Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  8. North America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  9. North America Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  10. North America Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  11. North America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  12. North America Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  13. North America Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  14. United States Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  15. United States Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  16. Canada Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  17. Canada Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  18. Europe Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  19. Europe Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  20. Europe Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  21. Europe Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  22. Europe Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  23. Europe Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  24. U.K. Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  25. U.K. Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  26. Germany Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  27. Germany Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  28. France Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  29. France Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  30. Italy Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  31. Italy Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  32. Spain Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  33. Spain Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  34. Asia Pacific Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  35. Asia Pacific Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  36. Asia Pacific Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  37. Asia Pacific Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  38. Asia Pacific Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  39. Asia Pacific Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  40. Japan Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  41. Japan Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  42. China Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  43. China Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  44. India Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  45. India Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  46. Australia Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  47. Australia Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  48. South Korea Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  49. South Korea Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  50. Latin America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  51. Latin America Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  52. Latin America Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  53. Latin America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  54. Latin America Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  55. Latin America Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  56. Brazil Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  57. Brazil Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  58. Argentina Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  59. Argentina Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  60. Mexico Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  61. Mexico Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  62. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  63. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  64. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  65. Middle East and Africa Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  66. Middle East and Africa Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  67. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  68. Middle East and Africa Diagnostics Market By Region, From 2016-2022 ( USD Billion )
  69. Middle East and Africa Therapeutics Market By Region, From 2016-2022 ( USD Billion )
  70. Middle East Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  71. Middle East Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
  72. Africa Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2016-2022 ( USD Billion )
  73. Africa Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2016-2022 ( USD Billion )
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.